PCNA and neoplasm: Immunohistochemical analysis of panobinostat-treated tumour tissue revealed a significant reduction in cell proliferation compared to vehicle control, as assessed by PCNA staining (vehicle, 93.7 ± 5.1 vs. panobinostat, 79.6 ± 4.5; p < 0.0001 (Figure 6a,b).